EE9900560A - 5-naftaleen-1-üül-1,3-dioksaani derivaadid, nende valmistamine ja terapeutiline kasutamine - Google Patents
5-naftaleen-1-üül-1,3-dioksaani derivaadid, nende valmistamine ja terapeutiline kasutamineInfo
- Publication number
- EE9900560A EE9900560A EEP199900560A EEP9900560A EE9900560A EE 9900560 A EE9900560 A EE 9900560A EE P199900560 A EEP199900560 A EE P199900560A EE P9900560 A EEP9900560 A EE P9900560A EE 9900560 A EE9900560 A EE 9900560A
- Authority
- EE
- Estonia
- Prior art keywords
- naphthalen
- preparation
- therapeutic use
- dioxane derivatives
- dioxane
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Ophthalmology & Optometry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9706947A FR2764291B1 (fr) | 1997-06-05 | 1997-06-05 | Derives de 5-naphtalen-1-yl-1,3-dioxane, leur preparation et leur application en therapeutique |
FR9706944A FR2764287B1 (fr) | 1997-06-05 | 1997-06-05 | Derives de 5-naphtalen-1-yl-1,3-dioxanes, leur preparation et leur application en therapeutique |
FR9706945A FR2764288B1 (fr) | 1997-06-05 | 1997-06-05 | Derives de 5-naphtalen-1-yl-1,3-dioxane, leur preparation et leur application en therapeutique |
FR9706946A FR2764289B1 (fr) | 1997-06-05 | 1997-06-05 | Derives de 5-naphtalen-1-yl-1,3-dioxane, leur preparation et leur application en therapeutique |
PCT/FR1998/001113 WO1998055474A1 (fr) | 1997-06-05 | 1998-06-03 | Derives de 5-naphtalen-1-yl-1,3-dioxane, leur preparation et leur application en therapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
EE9900560A true EE9900560A (et) | 2000-06-15 |
Family
ID=27447000
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP199900560A EE9900560A (et) | 1997-06-05 | 1998-06-03 | 5-naftaleen-1-üül-1,3-dioksaani derivaadid, nende valmistamine ja terapeutiline kasutamine |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0986552A1 (et) |
JP (1) | JP2002502412A (et) |
KR (1) | KR20010013435A (et) |
CN (1) | CN1265658A (et) |
AR (1) | AR012908A1 (et) |
AU (1) | AU8025198A (et) |
BG (1) | BG103937A (et) |
BR (1) | BR9810742A (et) |
CA (1) | CA2290695A1 (et) |
CO (1) | CO4940480A1 (et) |
EE (1) | EE9900560A (et) |
HU (1) | HUP0002166A3 (et) |
IL (1) | IL133242A0 (et) |
NO (1) | NO995966L (et) |
PL (1) | PL337234A1 (et) |
SK (1) | SK166199A3 (et) |
TR (1) | TR199903022T2 (et) |
WO (1) | WO1998055474A1 (et) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5271473B2 (ja) * | 2000-07-21 | 2013-08-21 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | 神経障害性疼痛ならびに群発性頭痛および偏頭痛に関連する疼痛の予防もしくは治療における使用のためのカルバメート化合物 |
FR2843964B1 (fr) * | 2002-08-29 | 2004-10-01 | Sanofi Synthelabo | Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0461958T3 (da) * | 1990-06-15 | 1995-02-20 | Synthelabo | 2-(aminoalkyl)-5-(arylalkyl)-1,3-dioxanderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf i terapien |
FR2714055B1 (fr) * | 1993-12-22 | 1996-01-19 | Synthelabo | Dérivés de 5-(arylalkyl)-1,3-dioxane substitués en position 2, leur préparation et leur utilisation en thérapeutique. |
FR2742152B1 (fr) * | 1995-12-06 | 1998-01-16 | Synthelabo | Derives de 5-naphtalen-1-yl-1,3-dioxanes, leur preparation et leur application en therapeutique |
-
1998
- 1998-06-03 AU AU80251/98A patent/AU8025198A/en not_active Abandoned
- 1998-06-03 IL IL13324298A patent/IL133242A0/xx unknown
- 1998-06-03 KR KR1019997011436A patent/KR20010013435A/ko not_active Application Discontinuation
- 1998-06-03 WO PCT/FR1998/001113 patent/WO1998055474A1/fr not_active Application Discontinuation
- 1998-06-03 HU HU0002166A patent/HUP0002166A3/hu unknown
- 1998-06-03 EP EP98928419A patent/EP0986552A1/fr not_active Withdrawn
- 1998-06-03 BR BR9810742-9A patent/BR9810742A/pt not_active IP Right Cessation
- 1998-06-03 TR TR1999/03022T patent/TR199903022T2/xx unknown
- 1998-06-03 EE EEP199900560A patent/EE9900560A/et unknown
- 1998-06-03 CA CA002290695A patent/CA2290695A1/en not_active Abandoned
- 1998-06-03 PL PL98337234A patent/PL337234A1/xx unknown
- 1998-06-03 CN CN98807817A patent/CN1265658A/zh active Pending
- 1998-06-03 JP JP50172399A patent/JP2002502412A/ja active Pending
- 1998-06-03 SK SK1661-99A patent/SK166199A3/sk unknown
- 1998-06-03 AR ARP980102585A patent/AR012908A1/es unknown
- 1998-06-04 CO CO98031750A patent/CO4940480A1/es unknown
-
1999
- 1999-11-30 BG BG103937A patent/BG103937A/xx unknown
- 1999-12-03 NO NO995966A patent/NO995966L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU8025198A (en) | 1998-12-21 |
NO995966D0 (no) | 1999-12-03 |
KR20010013435A (ko) | 2001-02-26 |
PL337234A1 (en) | 2000-08-14 |
SK166199A3 (en) | 2000-06-12 |
AR012908A1 (es) | 2000-11-22 |
EP0986552A1 (fr) | 2000-03-22 |
JP2002502412A (ja) | 2002-01-22 |
CN1265658A (zh) | 2000-09-06 |
BR9810742A (pt) | 2000-09-12 |
CA2290695A1 (en) | 1998-12-10 |
HUP0002166A2 (hu) | 2001-06-28 |
HUP0002166A3 (en) | 2002-12-28 |
NO995966L (no) | 2000-02-04 |
WO1998055474A1 (fr) | 1998-12-10 |
CO4940480A1 (es) | 2000-07-24 |
IL133242A0 (en) | 2001-03-19 |
BG103937A (en) | 2000-07-31 |
TR199903022T2 (xx) | 2000-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE04151B1 (et) | Atsüülpiperasinüülpürimidiinide derivaadid, nendevalmistamine ja kasutamine ravimitena | |
DK0869126T3 (da) | Dithiolanderivater, deres fremstilling og deres terapeutiske virkning | |
EE200000658A (et) | CD23 antikehad, nende derivaadid ja nende terapeutiline kasutamine | |
EE9800459A (et) | Spiro-piperidiini derivaadid ja nende kasutamine terapeutiliste toimeainetena | |
FI955235A0 (fi) | Oksatsolidiinionijohdannaiset, niiden valmistus ja käyttö | |
IS5760A (is) | Meðferðarlegar bíarýl afleiður | |
EE04497B1 (et) | Püridopüranoasepiini derivaadid, nende valmistamine ja terapeutiline kasutamine | |
CY2013003I1 (el) | Φωσφονοκεφεμικα παραγωγα, διαδικασια για την παρασκευη τους, και χρηση αυτων | |
EE04721B1 (et) | Fenüülksantiini derivaadid, nende valmistamismeetodid ja kasutamine | |
EE200200160A (et) | 2'-asendatud 1,1'-bifenüül-2-karboksamiidid, nende kasutamine ja farmatseutilised preparaadid | |
EE9600172A (et) | Puriin-6-ooni derivaadid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja ravimid | |
EE200000621A (et) | Pikornaviirusevastased ühendid, nende valmistamine ja kasutamine | |
FI956298A0 (fi) | 3-fenyyli-isokinolin-1(2H)-oneja, niiden valmistus ja terapeuttinen käyttö | |
EE9800145A (et) | Fenüülamidiini derivaadid, meetodid nende valmistamiseks ja nende kasutamine arstimitena | |
NO992676D0 (no) | 1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse | |
EE9800333A (et) | Uued furaandiarüülmetülideeni derivaadid, nende valmistamise meetod ja kasutamine teraapias | |
EE200000207A (et) | 8-asabitsüklo[3.2.1]oktaan-3-metaanamiini derivaadid, nende valmistamine ja terapeutiline kasutamine | |
EE200000018A (et) | 6-pürrolidiin-2-üülpüridiinid, nende valmistamine ja terapeutiline kasutamine | |
FI971317A (fi) | Uusia heterosyklisiä, substituoituja imidatsolokinoksalinoneja, niiden valmistus ja käyttö | |
EE9800153A (et) | 5-naftalen-1-üül-1,3-dioksaani derivaadid, nende valmistamine ja terapeutiline kasutamine | |
FI956251A (fi) | 1-okso-2-(fenyylisulfonyyliamino)pentyylipiperidiinijohdannaiset, niiden valmistus ja terapeuttinen käyttö | |
EE9900560A (et) | 5-naftaleen-1-üül-1,3-dioksaani derivaadid, nende valmistamine ja terapeutiline kasutamine | |
EE9800163A (et) | Uued kinoksaliindiooni derivaadid, nende valmistamine ja ravimitena kasutamine | |
ZA984854B (en) | 5-Naphthalene-1-YL-1,3-Dioxane derivatives their preparation and their therapeutic application | |
FR2764289B1 (fr) | Derives de 5-naphtalen-1-yl-1,3-dioxane, leur preparation et leur application en therapeutique |